Logo image of SDGR

SCHRODINGER INC (SDGR) Stock Fundamental Analysis

USA - NASDAQ:SDGR - US80810D1037 - Common Stock

19.71 USD
-0.33 (-1.65%)
Last: 9/30/2025, 3:00:00 PM
Fundamental Rating

4

Taking everything into account, SDGR scores 4 out of 10 in our fundamental rating. SDGR was compared to 35 industry peers in the Health Care Technology industry. SDGR has a great financial health rating, but its profitability evaluates not so good. SDGR is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year SDGR has reported negative net income.
In the past year SDGR had a positive cash flow from operations.
In the past 5 years SDGR reported 4 times negative net income.
SDGR had negative operating cash flow in 4 of the past 5 years.
SDGR Yearly Net Income VS EBIT VS OCF VS FCFSDGR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 -50M -100M -150M -200M

1.2 Ratios

SDGR has a Return On Assets of -26.35%. This is comparable to the rest of the industry: SDGR outperforms 42.86% of its industry peers.
SDGR has a Return On Equity of -52.89%. This is comparable to the rest of the industry: SDGR outperforms 42.86% of its industry peers.
Industry RankSector Rank
ROA -26.35%
ROE -52.89%
ROIC N/A
ROA(3y)-13.11%
ROA(5y)-11.18%
ROE(3y)-23.43%
ROE(5y)-18.45%
ROIC(3y)N/A
ROIC(5y)N/A
SDGR Yearly ROA, ROE, ROICSDGR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 0 -10 -20 -30 -40

1.3 Margins

SDGR's Gross Margin of 58.48% is in line compared to the rest of the industry. SDGR outperforms 51.43% of its industry peers.
In the last couple of years the Gross Margin of SDGR has grown nicely.
The Profit Margin and Operating Margin are not available for SDGR so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 58.48%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y10.19%
GM growth 5Y2.08%
SDGR Yearly Profit, Operating, Gross MarginsSDGR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100

More info and screens

7

2. Health

2.1 Basic Checks

SDGR does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, SDGR has more shares outstanding
The number of shares outstanding for SDGR has been increased compared to 5 years ago.
There is no outstanding debt for SDGR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
SDGR Yearly Shares OutstandingSDGR Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
SDGR Yearly Total Debt VS Total AssetsSDGR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

SDGR has an Altman-Z score of 1.33. This is a bad value and indicates that SDGR is not financially healthy and even has some risk of bankruptcy.
SDGR has a Altman-Z score (1.33) which is comparable to the rest of the industry.
There is no outstanding debt for SDGR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 1.33
ROIC/WACCN/A
WACC9.79%
SDGR Yearly LT Debt VS Equity VS FCFSDGR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

2.3 Liquidity

SDGR has a Current Ratio of 3.30. This indicates that SDGR is financially healthy and has no problem in meeting its short term obligations.
SDGR has a Current ratio of 3.30. This is in the better half of the industry: SDGR outperforms 77.14% of its industry peers.
A Quick Ratio of 3.30 indicates that SDGR has no problem at all paying its short term obligations.
The Quick ratio of SDGR (3.30) is better than 77.14% of its industry peers.
Industry RankSector Rank
Current Ratio 3.3
Quick Ratio 3.3
SDGR Yearly Current Assets VS Current LiabilitesSDGR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

More info and screens

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 10.47% over the past year.
Looking at the last year, SDGR shows a quite strong growth in Revenue. The Revenue has grown by 18.59% in the last year.
SDGR shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 19.41% yearly.
EPS 1Y (TTM)10.47%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%20.27%
Revenue 1Y (TTM)18.59%
Revenue growth 3Y14.6%
Revenue growth 5Y19.41%
Sales Q2Q%15.69%

3.2 Future

Based on estimates for the next years, SDGR will show a quite strong growth in Earnings Per Share. The EPS will grow by 12.80% on average per year.
The Revenue is expected to grow by 20.32% on average over the next years. This is a very strong growth
EPS Next Y7.3%
EPS Next 2Y12.59%
EPS Next 3Y12.8%
EPS Next 5YN/A
Revenue Next Year23.38%
Revenue Next 2Y21.56%
Revenue Next 3Y15.96%
Revenue Next 5Y20.32%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
SDGR Yearly Revenue VS EstimatesSDGR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 200M 400M 600M 800M 1B
SDGR Yearly EPS VS EstimatesSDGR Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 -1 -2

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for SDGR. In the last year negative earnings were reported.
Also next year SDGR is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SDGR Price Earnings VS Forward Price EarningsSDGR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Price/Free Cash Flow ratio of SDGR is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 59.53
EV/EBITDA N/A
SDGR Per share dataSDGR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4

4.3 Compensation for Growth

A more expensive valuation may be justified as SDGR's earnings are expected to grow with 12.80% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y12.59%
EPS Next 3Y12.8%

More info and screens

0

5. Dividend

5.1 Amount

SDGR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SCHRODINGER INC

NASDAQ:SDGR (9/30/2025, 3:00:00 PM)

19.71

-0.33 (-1.65%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)08-06 2025-08-06/amc
Earnings (Next)11-10 2025-11-10/amc
Inst Owners108.15%
Inst Owner Change6.91%
Ins Owners2.65%
Ins Owner Change0.81%
Market Cap1.45B
Analysts80
Price Target28.67 (45.46%)
Short Float %16.77%
Short Ratio9.07
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)8.6%
Min EPS beat(2)-7.46%
Max EPS beat(2)24.66%
EPS beat(4)2
Avg EPS beat(4)0.77%
Min EPS beat(4)-28.59%
Max EPS beat(4)24.66%
EPS beat(8)4
Avg EPS beat(8)-0.84%
EPS beat(12)8
Avg EPS beat(12)15.13%
EPS beat(16)9
Avg EPS beat(16)10.08%
Revenue beat(2)2
Avg Revenue beat(2)5.03%
Min Revenue beat(2)3.23%
Max Revenue beat(2)6.83%
Revenue beat(4)3
Avg Revenue beat(4)-0.15%
Min Revenue beat(4)-14.72%
Max Revenue beat(4)6.83%
Revenue beat(8)5
Avg Revenue beat(8)0.64%
Revenue beat(12)7
Avg Revenue beat(12)2.42%
Revenue beat(16)10
Avg Revenue beat(16)5.56%
PT rev (1m)2.97%
PT rev (3m)-11.54%
EPS NQ rev (1m)-0.91%
EPS NQ rev (3m)8.1%
EPS NY rev (1m)0.21%
EPS NY rev (3m)11.34%
Revenue NQ rev (1m)0.83%
Revenue NQ rev (3m)2.89%
Revenue NY rev (1m)-0.87%
Revenue NY rev (3m)-1.46%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 6.1
P/FCF 59.53
P/OCF 52.77
P/B 4.23
P/tB 4.29
EV/EBITDA N/A
EPS(TTM)-2.48
EYN/A
EPS(NY)-1.88
Fwd EYN/A
FCF(TTM)0.33
FCFY1.68%
OCF(TTM)0.37
OCFY1.9%
SpS3.23
BVpS4.66
TBVpS4.59
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -26.35%
ROE -52.89%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 58.48%
FCFM 10.24%
ROA(3y)-13.11%
ROA(5y)-11.18%
ROE(3y)-23.43%
ROE(5y)-18.45%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y10.19%
GM growth 5Y2.08%
F-Score5
Asset Turnover0.35
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA N/A
Cap/Depr 48.51%
Cap/Sales 1.31%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.3
Quick Ratio 3.3
Altman-Z 1.33
F-Score5
WACC9.79%
ROIC/WACCN/A
Cap/Depr(3y)181.56%
Cap/Depr(5y)173.13%
Cap/Sales(3y)4.71%
Cap/Sales(5y)4.34%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)10.47%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%20.27%
EPS Next Y7.3%
EPS Next 2Y12.59%
EPS Next 3Y12.8%
EPS Next 5YN/A
Revenue 1Y (TTM)18.59%
Revenue growth 3Y14.6%
Revenue growth 5Y19.41%
Sales Q2Q%15.69%
Revenue Next Year23.38%
Revenue Next 2Y21.56%
Revenue Next 3Y15.96%
Revenue Next 5Y20.32%
EBIT growth 1Y6.33%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year25.01%
EBIT Next 3Y17.97%
EBIT Next 5YN/A
FCF growth 1Y121.16%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y126.23%
OCF growth 3YN/A
OCF growth 5YN/A